PSA (PSORIATIC ARTHRITIS)
Clinical trials for PSA (PSORIATIC ARTHRITIS) explained in plain language.
Never miss a new study
Get alerted when new PSA (PSORIATIC ARTHRITIS) trials appear
Sign up with your email to follow new studies for PSA (PSORIATIC ARTHRITIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could ease joint pain for psoriatic arthritis patients
Disease control Recruiting nowThis study tests a new drug called D-2570 for people with active psoriatic arthritis, a condition causing joint pain and swelling. About 222 adults aged 18-70 will receive either the drug or a placebo to see if it reduces tender and swollen joints after 12 weeks. The goal is to f…
Matched conditions: PSA (PSORIATIC ARTHRITIS)
Phase: PHASE2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
New drug hopes to ease joint pain for arthritis sufferers
Disease control Recruiting nowThis study tests a new medicine called SPY002-072 in adults with moderate-to-severe rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis. About 285 participants will receive either the drug or a placebo to see if it reduces joint swelling and pain. The goal is to…
Matched conditions: PSA (PSORIATIC ARTHRITIS)
Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC